Entero Healthcare Solutions Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-24🗂️ Report periods on file: 2023-24

In its 2023-24 reporting, Entero Healthcare Solutions Limited disclosed greenhouse gas emissions of 4.1K kilolitres. By scope: Scope 1: 1.2K Metric tonnes of CO2 equivalent; Scope 2: 3.9K Metric tonnes of CO2 equivalent; Scope 3: 63.7K Metric tonnes of CO2 equivalent. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
4.1K kilolitres
2023-24
💧
Water Usage
40.6K kilolitres
2023-24
♻️
Waste
391.00 metric tonnes
2023-24
⚙️
Energy Use
177.6M Megajoules
2023-24

📊 Emissions by Scope (2023-24)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).1.2K Metric tonnes of CO2 equivalent
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.3.9K Metric tonnes of CO2 equivalent
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).63.7K Metric tonnes of CO2 equivalent

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Employee well-beingGHG emissionsBusiness ethicsManaging fleet fuelCustomer welfare

⚠️ Challenges & Risks +

  • M&A Risk: Failure to identify, complete, and successfully integrate acquisitions.
  • Liquidity Risk: Lack of available liquid financial assets.
  • Supply Chain Disruption Risk: Lack of control over product supply from suppliers.
  • Technology Risk: Loss of data and unauthorized access to IT systems.
  • Talent Acquisition and Retention Risk: High attrition rates.
  • Operations Risk: Disruption to warehouse operations or new facility development.
  • Product Quality Risk: Distributing expired, defective, or counterfeit products.

📋 Report Information

Reporting Period: 2023-24
Frameworks: BRSR